Answer
Adjuvanted Trivalent Influenza Vaccine Seqirus induces antibodies against haemagglutinins that neutralise its three influenza strains (two A subtypes and one B type), while its MF59C.1 adjuvant is designed to increase, broaden and prolong the antigen-specific immune response.
Sources for this answer
- adjuvanted Trivalent Influenza VaccineSeqirus UK Limited · emc · SmPC §5.1 Pharmacodynamic properties · Version 4Document updated
Sources checked